Ascendis Pharma A/S (ASND)
NASDAQ·Healthcare·Biotechnology
$221.05
+2.53%
Mkt Cap $14.73B
Analyst Ratings
No recent rating data.
Price Target (40 analysts)
$287.17
Range $250.00 – $342.00
Implied Upside
+29.9%
Consensus $287.17 vs current $221.05
NASDAQ·Healthcare·Biotechnology
$221.05
+2.53%
Mkt Cap $14.73B
No recent rating data.
Price Target (40 analysts)
$287.17
Range $250.00 – $342.00
+29.9%
Consensus $287.17 vs current $221.05